These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency]. Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849 [TBL] [Abstract][Full Text] [Related]
3. [Erythropoietin, a milestone in the history of nephrology]. Uehlinger DE; Frey FJ Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378 [TBL] [Abstract][Full Text] [Related]
4. [Anemia and progression of renal failure]. Gellert R Pol Arch Med Wewn; 2002 Apr; 107(4):375-7. PubMed ID: 12189930 [No Abstract] [Full Text] [Related]
5. [Does erythropoietin restrict lef ventricular hypertrophy in patients with chronic renal failure?]. Switalski M; Boniecka Z; Gellert R Pol Arch Med Wewn; 2002 Apr; 107(4):389-92. PubMed ID: 12189932 [No Abstract] [Full Text] [Related]
8. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure]. Schaefer RM; Heidland A Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190 [No Abstract] [Full Text] [Related]
9. The effects of recombinant human erythropoietin on mean corpuscular volume in patients with the anemia of chronic renal failure. Schwartz AB; Orquiza CS Clin Nephrol; 1995 Apr; 43(4):256-9. PubMed ID: 7606880 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin. Erslev AJ N Engl J Med; 1991 May; 324(19):1339-44. PubMed ID: 2017231 [No Abstract] [Full Text] [Related]
11. Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin. Abels R Semin Nephrol; 1990 Mar; 10(2 Suppl 1):20-5. PubMed ID: 2192413 [No Abstract] [Full Text] [Related]
12. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group. Keown PA Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199 [No Abstract] [Full Text] [Related]
13. Effect of recombinant human erythropoietin on the anemia of chronic renal failure. Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592 [TBL] [Abstract][Full Text] [Related]
14. Recombinant erythropoietin: 10 years of clinical experience. Valderrábano F Nephrol Dial Transplant; 1997; 12 Suppl 1():2-9. PubMed ID: 9075222 [No Abstract] [Full Text] [Related]
15. EPO--one year later. Fighting anemia in the courtroom. Riley JB; Pristave RJ Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877 [No Abstract] [Full Text] [Related]
16. [Erythropoietin: its biological properties and clinical use]. Ermolenko VM; Nikolaev AIu Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979 [No Abstract] [Full Text] [Related]
17. [Treatment of anemia in chronically dialyzed patients]. Moynot A Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055 [No Abstract] [Full Text] [Related]
18. EPO--one year later. Effects of EPO on nutritional status in CRF. Schiro KB Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876 [No Abstract] [Full Text] [Related]
19. Recombinant erythropoietin for the anemia of chronic renal failure. Ahmad R; Hand M N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706 [No Abstract] [Full Text] [Related]
20. Pressure sore anemia: response to erythropoietin. Turba RM; Lewis VL; Green D Arch Phys Med Rehabil; 1992 May; 73(5):498-500. PubMed ID: 1580782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]